XML 23 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Operating Activities      
Net income $ 5,153 $ 2,310 $ 1,543
Adjustments to reconcile to net cash provided by operating activities:      
Depreciation 324 281 306
Amortization 586 604 711
Loss (gain) from sales of businesses 94 (103) 0
Goodwill and other impairment charges 290 8 241
Deferred taxes 882 64 171
Share-based compensation expense 115 123 174
Charges (credits) associated with last-in-first-out inventory method (7) 244 337
Other non-cash items 88 108 47
Changes in operating assets and liabilities, net of acquisitions:      
Receivables (762) (1,957) (2,821)
Inventories 320 (1,251) (2,144)
Drafts and accounts payable 2,070 3,302 4,718
Deferred revenue (87) (120) (141)
Taxes 146 (78) (222)
Claim and litigation charges (credit) (6) 0 150
Litigation settlement payment (150) 0 0
Other (365) 137 42
Net cash provided by operating activities 4,744 3,672 3,112
Investing Activities      
Payments for property, plant and equipment (404) (488) (376)
Capitalized software expenditures (158) (189) (169)
Acquisitions, net of cash and cash equivalents acquired (4,237) (40) (170)
Proceeds from/(payment for) sale of businesses and other assets, net 206 210 15
Restricted cash for acquisitions (506) (939) 0
Other 75 (111) 23
Net cash used in investing activities (3,796) (1,557) (677)
Financing Activities      
Proceeds from short-term borrowings 8,294 1,561 3,100
Repayments of short-term borrowings (8,124) (1,688) (3,152)
Proceeds from issuances of long-term debt 1,824 0 3
Repayments of long-term debt (1,601) (1,598) (353)
Common stock transactions:      
Issuances 120 123 152
Share repurchases, including shares surrendered for tax withholding (2,311) (1,612) (450)
Dividends paid (253) (244) (227)
Other (18) 5 (41)
Net cash used in financing activities (2,069) (3,453) (968)
Effect of exchange rate changes on cash and cash equivalents (144) 45 (319)
Net increase (decrease) in cash and cash equivalents (1,265) (1,293) 1,148
Cash and cash equivalents at beginning of year 4,048 5,341 4,193
Cash and cash equivalents at end of year 2,783 4,048 5,341
Cash paid for:      
Interest 315 337 359
Income taxes, net of refunds 587 923 866
Healthcare Technology Net Asset Exchange      
Adjustments to reconcile to net cash provided by operating activities:      
Loss (gain) from sales of businesses (3,947) 0 0
Investing Activities      
Proceeds from/(payment for) sale of businesses and other assets, net $ 1,228 $ 0 $ 0